Adventitious agent risk assessment case study: Evaluation of RotaTeq® for the presence of porcine circovirus

PDA Journal of Pharmaceutical Science and Technology

Volumn 65, Issue 6, 2011, Pages 589-598

  Ranucci, C S ^a   Tagmyer, T ^a   Duncan, P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adventitious agents; Animal derived raw materials; Porcine circovirus

Indexed keywords

DEOXYRIBONUCLEASE; DNA FRAGMENT; MONOCLONAL ANTIBODY; ROTA TEQ; ROTAVIRUS VACCINE; TRYPSIN; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT;

CELL ASSAY; CIRCOVIRUS; CONFERENCE PAPER; DNA REPLICATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENOME; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIMIT OF DETECTION; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; GENETICS; HUMAN; MEDICAL RESEARCH; RISK ASSESSMENT;

BIOLOGICAL PRODUCTS; BIOMEDICAL RESEARCH; CIRCOVIRUS; HUMANS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 84855530765     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: 10.5731/pdajpst.2011.00827     Document Type: Conference Paper

References (10)

1. Willkommen, H.; Scheiblauer, H.; Lowrer, J. Serum and serum substitutes: virus safety by inactivation or removal. Dev. Biol. Stand. 1999, 99, 131-138.
2. Pavsic, M. Z.; Bolin, S. Resistance of bovine circovirus to gamma irradiation. BioPharm International 2001, 14 (4), 32-37.
3. Guidance for Industry - Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, February 2010.
4. Victoria, J. G.; Wang, C.; Jones, M. S.; Jaing, C.; McLoughlin, K.; Gardner, S.; Delwart, E. L. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84 (12), 6033-6040.
5. Finsterbusch, T.; Mankertz, A. Porcine circoviruses - small but powerful. Virus Res. 2009, 143 (2), 177-183.
6. Li, L.; Kapoor, A.; Slikas, B.; Bamidele, O. S.; Wang, C.; Shaukat, S.; Masroor, M. A.; Wilson, M. L.; Ndjango, J.-B. N.; Peeters, M.; Gross-Camp, N. D.; Muller, M. N.; Hahn, B. H.; Wolfe, N. D.; Triki, H.; Bartkus, J.; Zaidi, S. Z.; Delwart, E. Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J. Virol. 2010, 84 (4), 1674-1682.
7. fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm212140.htm
8. Gillespie, J.; Opriessnig, T.; Meng, X. J.; Pelzer, K.; Buechner-Maxwell, V. Porcine circovirus type 2 and porcine circovirus-associated disease. J. Vet. Intern. Med. 2009, 23 (6), 1151-1163.
9. Fenaux, M.; Opriessnig, T.; Halbur, P. G.; Xu, Y.; Potts, B.; Meng, X.-J. Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J. Gen. Virol. 2004, 85 (11), 3377-3382. (Pubitemid 39445457)
10. McClenahan, S.; Krause, P. R.; Uhlenhaut, C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29 (29-30), 4745-4753.